Patient's question:
Patient is male and was diagnosed with pulmonary hemosiderosis at the age of 3.5 years.Doctor's answer:
Childhood Idiopathic Pulmonary Hemochromatosis (IPH) is a group of pulmonary alveolar capillary hemorrhagic diseases, often recurrent, characterized by the accumulation of large amounts of hemosiderin in the lungs. A lack of awareness or insufficient understanding of this disease will delay diagnosis, affecting the pulmonary fibrosis process and prognosis in children. There is no specific treatment for this disease; the first-line treatment is adrenal corticosteroids, with maintenance therapy lasting 1 to 2 years. Premature discontinuation of medication is prone to recurrence.